CircARVCF Contributes to Cisplatin Resistance in Gastric Cancer by Altering miR-1205 and FGFR1
Background: Chemoresistance is a major barrier to the treatment of human cancers. Circular RNAs (circRNAs) are implicated in drug resistance in cancers, including gastric cancer (GC). In this study, we aimed to explore the functions of circRNA Armadillo Repeat gene deleted in Velo-Cardio-Facial synd...
Enregistré dans:
Auteurs principaux: | Ruirui Zhang, Huanyu Zhao, Hongmei Yuan, Jian Wu, Haiyan Liu, Suan Sun, Zhengwei Zhang, Jiayang Wang |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/21c4b1cf5ee84b2ca87038a76320c4ca |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Biological Significance and Targeting of the FGFR Axis in Cancer
par: Athina-Myrto Chioni, et autres
Publié: (2021) -
Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1
par: Zhang,Yun, et autres
Publié: (2020) -
Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation
par: Yunju Nam, et autres
Publié: (2022) -
FGF/FGFR-Dependent Molecular Mechanisms Underlying Anti-Cancer Drug Resistance
par: Jakub Szymczyk, et autres
Publié: (2021) -
Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2
par: Simone Romagnoli, et autres
Publié: (2021)